Showing 1 - 2 results of 2 for search 'Charles J. Link', query time: 0.02s Refine Results
  1. 1
    Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.

    Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses. by Wenlan Alex Chen, Jinjin Zhang, Katie M Hall, Carol B Martin, Serguei Kisselev, Emily J Dasen, Nicholas N Vahanian, Charles J Link, Brian K Martin

    Published 2017-01-01
    Get full text
    Article
  2. 2
    Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

    Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors by Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, Robin Dobbins, Lisa Marshall, Nicholas N. Vahanian, W. Jay Ramsey, Eugene Kennedy, Mario R. Mautino, Charles J. Link, Ray S. Lin, Stephanie Royer-Joo, Xiaorong Liang, Laurent Salphati, Kari M. Morrissey, Sami Mahrus, Bruce McCall, Andrea Pirzkall, David H. Munn, John E. Janik, Samir N. Khleif

    Published 2018-06-01
    Get full text
    Article

Search Tools: